{"id":2899829,"date":"2023-09-25T08:57:38","date_gmt":"2023-09-25T12:57:38","guid":{"rendered":"https:\/\/wordpress-1016567-4521551.cloudwaysapps.com\/plato-data\/imagebiposy-and-radiobotics-partner-to-develop-ai-assisted-diagnostics\/"},"modified":"2023-09-25T08:57:38","modified_gmt":"2023-09-25T12:57:38","slug":"imagebiposy-and-radiobotics-partner-to-develop-ai-assisted-diagnostics","status":"publish","type":"station","link":"https:\/\/platodata.io\/plato-data\/imagebiposy-and-radiobotics-partner-to-develop-ai-assisted-diagnostics\/","title":{"rendered":"ImageBiposy and Radiobotics partner to develop AI-assisted diagnostics"},"content":{"rendered":"

<!–<\/p>\n

\n

–> <\/p>\n

\n
According to ImageBiopsy Lab and Radiobotics, their AI-assisted technology will support disease diagnosis in musculoskeletal, orthopaedic, and trauma use cases. Image Credit: Phonlamai Photo \/ Shutterstock.<\/figcaption><\/figure>\n<\/p><\/div>\n

Austria-based ImageBiopsy Lab has partnered with Danish company Radiobotics to implement artificial intelligence (AI) assisted disease diagnostics in the Germany, Austria, and Switzerland (DACH) region.<\/p>\n

The use of AI in assisting disease diagnostics<\/a> has increased in recent years. According to a report by GlobalData, the AI market will be worth $93bn<\/a> this year. The analysis also identifies AI-assisted radiology as an emerging and disruptive technology that should be tracked closely, with Dutch conglomerate Philips being one of the leading patent filers in AI-assisted CT imaging<\/a>.<\/p>\n

According to ImageBiopsy Lab and Radiobotics, their AI-assisted technology will support disease diagnosis<\/a> in musculoskeletal, orthopaedic, and trauma use cases. The technology is expected to reduce the manual interpretation of X-rays and MRI images, thereby increasing efficiency.<\/p>\n

The technology will analyse imaging and conduct any measurement and scoring to help in interpretation and reduce manual load. It could also help with fracture detection workflow.<\/p>\n

\u201cBefore even considering the use of AI, it\u2019s crucial to grasp physicians\u2019 diagnostic workflow and needs,\u201d said ImageBiopsy Lab CEO Dr Richard Ljuhar.<\/p>\n

\u201cFor this purpose, we\u2019ve closely collaborated with leading musculoskeletal radiologists, orthopaedics, and traumatologists over the past years.\u201d<\/p>\n

ImageBiopsy has a US Food and Drug Administration (FDA)-approved radiological image processing software<\/a>, IB Lab LAMA. It provides limb and angle measurements on leg X-rays, which can used by orthopaedic surgeons to manage their patients. <\/p>\n

The other products in the company\u2019s catalogue include IB Lab KOALA, which can detect signs of knee osteoarthritis using joint measurements; and IB Lab SQUIRREL module<\/a> for scoliosis assessment.<\/p>\n

Radiobotics has a fracture detection AI software, RBfracture, which highlights the possible fracture locations in each X-ray therapy, thereby reducing the time to analyse, especially in trauma settings.<\/p>\n

Share this article<\/span> <\/div>\n